123, Aug
Many of these compounds have been sold for decades in teas, powders, and pills with little to no meaningful impact on weight loss
A lower 4mg weekly dose also resulted in impressive weight loss results, with an average loss of 17% over 48 weeks and: 92% of participants lost at least 5% of their starting body weight 75% lost at least 10% of their body weight 60% lost at least 15% of their starting weight Retatrutide vs Mounjaro In clinical trials, the active ingredient in Mounjaro, tirzepatide, results in an average weight loss of 22.5% at the highest 15mg per week dose over 72 weeks
CrossRef Association Between Metabolically Associated Steatotic Liver Disease (MASLD) and Cardiovascular Risk Scores in Urban Adults FARIS HUSSAIN, KELVIN KANAYO NWABUEZE, FATIMA IJAZ, SONIA OUTALEB, MAHMUDUL HASAN NAHID, SYED ABID, MARIAM SALEEM, KHANT NYI ZAYA, SAIFULLAH SYED, HUMAIRA JANANTH, MANAHIL ZARIEF Juntendo Medical Journal .2026
Severe gastroparesis is another major concern because both products are not recommended in patients with this condition
It says that conversation may cover adjusting treatment, switching to a different agent in the class, or reconsidering whether the therapy fits at all, and that a clinician is needed to separate medication-related headaches from other causes